Chlorpromazine has intracellular killing activity against phagocytosed Staphylococcus aureus at clinical concentrations

Diane Ordway, Miguel Viveiros, Clara Leandro, Maria Jorge Arroz, J. Molnár, Jette E. Kristiansen, Leonard Amaral

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Chlorpromazine (CPZ) has in vitro antimicrobial activity against Staphylococcus aureus at concentrations that greatly exceed those achieved clinically. It is concentrated by tissues that are rich in macrophages and it is active against phagocytosed mycobacteria when the concentration in the medium is compatible with that achieved clinically. In this report we show that nontoxic concentrations of CPZ below clinical levels have killing activity against S. aureus phagocytosed by human monocyte-derived macrophages that have nominal killing activity against these bacteria, Little or no resistance to the antimicrobial activity of this compound is anticipated to result because of its large number of cellular targets. Therefore, CPZ may have a role in the management of intracellular staphylococcal infections that normally require the use of antibiotics whose potential toxicity exceeds that associated with short-term management with CPZ.

Original languageEnglish
Pages (from-to)227-231
Number of pages5
JournalJournal of Infection and Chemotherapy
Volume8
Issue number3
DOIs
Publication statusPublished - Sep 2002

Fingerprint

Chlorpromazine
Phagocytosis
Staphylococcus aureus
Macrophages
Staphylococcal Infections
Mycobacterium
Anti-Bacterial Agents
Bacteria

Keywords

  • Cellular immunity
  • Chlorpromazine
  • Intracellular activity
  • Staphylococcus aureus

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Chlorpromazine has intracellular killing activity against phagocytosed Staphylococcus aureus at clinical concentrations. / Ordway, Diane; Viveiros, Miguel; Leandro, Clara; Arroz, Maria Jorge; Molnár, J.; Kristiansen, Jette E.; Amaral, Leonard.

In: Journal of Infection and Chemotherapy, Vol. 8, No. 3, 09.2002, p. 227-231.

Research output: Contribution to journalArticle

Ordway, Diane ; Viveiros, Miguel ; Leandro, Clara ; Arroz, Maria Jorge ; Molnár, J. ; Kristiansen, Jette E. ; Amaral, Leonard. / Chlorpromazine has intracellular killing activity against phagocytosed Staphylococcus aureus at clinical concentrations. In: Journal of Infection and Chemotherapy. 2002 ; Vol. 8, No. 3. pp. 227-231.
@article{fbbd1b906f15422882fa3d64fde42ac9,
title = "Chlorpromazine has intracellular killing activity against phagocytosed Staphylococcus aureus at clinical concentrations",
abstract = "Chlorpromazine (CPZ) has in vitro antimicrobial activity against Staphylococcus aureus at concentrations that greatly exceed those achieved clinically. It is concentrated by tissues that are rich in macrophages and it is active against phagocytosed mycobacteria when the concentration in the medium is compatible with that achieved clinically. In this report we show that nontoxic concentrations of CPZ below clinical levels have killing activity against S. aureus phagocytosed by human monocyte-derived macrophages that have nominal killing activity against these bacteria, Little or no resistance to the antimicrobial activity of this compound is anticipated to result because of its large number of cellular targets. Therefore, CPZ may have a role in the management of intracellular staphylococcal infections that normally require the use of antibiotics whose potential toxicity exceeds that associated with short-term management with CPZ.",
keywords = "Cellular immunity, Chlorpromazine, Intracellular activity, Staphylococcus aureus",
author = "Diane Ordway and Miguel Viveiros and Clara Leandro and Arroz, {Maria Jorge} and J. Moln{\'a}r and Kristiansen, {Jette E.} and Leonard Amaral",
year = "2002",
month = "9",
doi = "10.1007/s10156-002-0188-4",
language = "English",
volume = "8",
pages = "227--231",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Chlorpromazine has intracellular killing activity against phagocytosed Staphylococcus aureus at clinical concentrations

AU - Ordway, Diane

AU - Viveiros, Miguel

AU - Leandro, Clara

AU - Arroz, Maria Jorge

AU - Molnár, J.

AU - Kristiansen, Jette E.

AU - Amaral, Leonard

PY - 2002/9

Y1 - 2002/9

N2 - Chlorpromazine (CPZ) has in vitro antimicrobial activity against Staphylococcus aureus at concentrations that greatly exceed those achieved clinically. It is concentrated by tissues that are rich in macrophages and it is active against phagocytosed mycobacteria when the concentration in the medium is compatible with that achieved clinically. In this report we show that nontoxic concentrations of CPZ below clinical levels have killing activity against S. aureus phagocytosed by human monocyte-derived macrophages that have nominal killing activity against these bacteria, Little or no resistance to the antimicrobial activity of this compound is anticipated to result because of its large number of cellular targets. Therefore, CPZ may have a role in the management of intracellular staphylococcal infections that normally require the use of antibiotics whose potential toxicity exceeds that associated with short-term management with CPZ.

AB - Chlorpromazine (CPZ) has in vitro antimicrobial activity against Staphylococcus aureus at concentrations that greatly exceed those achieved clinically. It is concentrated by tissues that are rich in macrophages and it is active against phagocytosed mycobacteria when the concentration in the medium is compatible with that achieved clinically. In this report we show that nontoxic concentrations of CPZ below clinical levels have killing activity against S. aureus phagocytosed by human monocyte-derived macrophages that have nominal killing activity against these bacteria, Little or no resistance to the antimicrobial activity of this compound is anticipated to result because of its large number of cellular targets. Therefore, CPZ may have a role in the management of intracellular staphylococcal infections that normally require the use of antibiotics whose potential toxicity exceeds that associated with short-term management with CPZ.

KW - Cellular immunity

KW - Chlorpromazine

KW - Intracellular activity

KW - Staphylococcus aureus

UR - http://www.scopus.com/inward/record.url?scp=0036745629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036745629&partnerID=8YFLogxK

U2 - 10.1007/s10156-002-0188-4

DO - 10.1007/s10156-002-0188-4

M3 - Article

VL - 8

SP - 227

EP - 231

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

IS - 3

ER -